CO-EVOLVED THERAPEUTICS Trademark

Trademark Overview

On Tuesday, December 8, 2020, a trademark application was filed for CO-EVOLVED THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CO-EVOLVED THERAPEUTICS trademark a serial number of 90366077. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, July 9, 2024. This trademark is owned by Empress Therapeutics, Inc.. The CO-EVOLVED THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
co-evolved therapeutics

General Information

Serial Number90366077
Word MarkCO-EVOLVED THERAPEUTICS
Filing DateTuesday, December 8, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 16, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmpress Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameEmpress Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, December 11, 2020NEW APPLICATION ENTERED
Friday, February 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 27, 2021ASSIGNED TO EXAMINER
Wednesday, June 2, 2021NON-FINAL ACTION E-MAILED
Wednesday, June 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 2, 2021NON-FINAL ACTION WRITTEN
Thursday, October 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 7, 2022SOU EXTENSION 1 GRANTED
Thursday, July 7, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 7, 2022SOU EXTENSION 1 FILED
Thursday, January 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 3, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 3, 2023SOU EXTENSION 2 FILED
Tuesday, January 3, 2023SOU EXTENSION 2 GRANTED
Thursday, July 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 6, 2023SOU EXTENSION 3 FILED
Thursday, July 6, 2023SOU EXTENSION 3 GRANTED
Saturday, July 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 4, 2024SOU EXTENSION 4 FILED
Thursday, January 4, 2024SOU EXTENSION 4 GRANTED
Saturday, January 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU EXTENSION 5 FILED
Tuesday, July 9, 2024SOU EXTENSION 5 GRANTED

Related Keywords

therapeutics evolved disorders diseases related endocrinological metabolic neurodegenerative neurological system immune therapeutic